Methyl 4-Methyl-3-((4-(Pyridin-3-yl)Pyrimidin-2-yl)Amino)Benzoate: A Key Intermediate for Nilotinib Synthesis

The crucial building block for advanced cancer therapy and pharmaceutical innovation.

Get a Quote & Sample

Key Advantages

Uncompromising Purity

Achieve superior results in your drug development projects with a compound boasting ≥99.0% assay (HPLC), minimizing impurities and ensuring batch consistency for Nilotinib synthesis.

Therapeutic Impact

Contribute to significant advancements in CML treatment by utilizing this essential precursor for Nilotinib Hydrochloride Monohydrate.

Manufacturing Reliability

Benefit from a pharmaceutical building block for oncology drugs with stable physical and chemical properties, ensuring predictable performance in complex synthesis processes.

Key Applications

Nilotinib Synthesis

This compound is the cornerstone for synthesizing Nilotinib, a crucial component in treating Chronic Myelogenous Leukemia, highlighting its role in oncology drug intermediate development.

Advanced Pharmaceutical Intermediates

Utilized in complex chemical synthesis, it serves as a vital precursor for cutting-edge pharmaceuticals, driving innovation in drug development.

Fine Chemical Engineering

Represents the sophisticated capabilities in fine chemical engineering required for producing high-value compounds critical for modern medicine.

Targeted Cancer Therapies

Plays an integral role in the production of targeted therapies like Nilotinib, directly impacting patient outcomes in cancer therapy.